Shockwave Medical (Nasdaq:SWAV) - Cours de l'action, nouvelles et analyse

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

SWAV Aperçu des actions

A medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.

A propos de l'entreprise

SWAV analyse fondamentale
Score flocon de neige
Évaluation	1/6
Croissance future	3/6
Performances passées	3/6
Santé financière	5/6
Dividendes	0/6

Récompenses

Les bénéfices devraient augmenter 18.35% par an

Analyse des risques

Les actionnaires ont été dilués au cours de l'année écoulée

Les marges bénéficiaires (20.7%) sont inférieures à celles de l'année dernière (43.2%)

Shockwave Medical, Inc. Concurrents

Insulet

NasdaqGS:PODD

US$12.7b

Teleflex

NYSE:TFX

US$11.4b

Masimo

NasdaqGS:MASI

US$6.3b

STERIS

NYSE:STE

US$23.2b

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Shockwave Medical
Historique des cours de bourse
Prix actuel de l'action	US$334.75
Plus haut sur 52 semaines	US$334.90
Plus bas sur 52 semaines	US$157.00
Bêta	0.88
1Variation sur 1 mois	1.49%
Variation sur 3 mois	27.08%
Variation sur 1 an	15.77%
3Variation sur 3 ans	97.43%
Variation sur 5 ans	432.11%
Évolution depuis l'introduction en bourse	997.54%

Nouvelles et mises à jour récentes

Recent updates

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Apr 06

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09

Rendement pour les actionnaires

	SWAV	US Medical Equipment	US Marché
7D	0.2%	0.9%	0.1%
1Y	15.8%	11.6%	24.9%

Rendement vs Industrie: SWAV a dépassé le secteur US Medical Equipment qui a rapporté 11.2 % au cours de l'année écoulée.

Rendement vs marché: SWAV a sous-performé le marché US qui a rapporté 25.6 % au cours de l'année écoulée.

Volatilité des prix

Is SWAV's price volatile compared to industry and market?
SWAV volatility
SWAV Average Weekly Movement	3.6%
Medical Equipment Industry Average Movement	8.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.1%
10% least volatile stocks in US Market	3.2%

Cours de l'action stable: SWAV n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de SWAV ( 4% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
2009	1,468	Doug Godshall	shockwavemedical.com

Shockwave Medical, Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Shockwave Medical se comparent-ils à sa capitalisation boursière ?
SWAV statistiques fondamentales
Capitalisation boursière	US$12.57b
Bénéfices(TTM)	US$163.50m
Recettes(TTM)	US$787.97m

76.9x

Ratio P/E

15.9x

Ratio P/S

Le site SWAV est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
SWAV compte de résultat (TTM)
Recettes	US$787.97m
Coût des recettes	US$102.53m
Marge brute	US$685.44m
Autres dépenses	US$521.94m
Les revenus	US$163.50m

Derniers bénéfices déclarés

Mar 31, 2024

Prochaine date de publication des résultats

Aug 05, 2024

Résultat par action (EPS)	4.35
Marge brute	86.99%
Marge bénéficiaire nette	20.75%
Ratio dettes/capitaux propres	97.5%

Quelles ont été les performances à long terme de SWAV?

Voir les performances historiques et les comparaisons

SWAV Aperçu des actions

Récompenses

Analyse des risques

Shockwave Medical, Inc. Concurrents

NasdaqGS:PODD

US$12.7b

NYSE:TFX

US$11.4b

NasdaqGS:MASI

US$6.3b

NYSE:STE

US$23.2b

Historique des prix et performances

Nouvelles et mises à jour récentes

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Recent updates

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Shockwave Medical, Inc., Annual General Meeting, May 29, 2024

Price target increased by 7.7% to US$302

Shockwave Medical, Inc. Announces Investigators Presented Six-Month Data from the Full Population of the Reducer-I Study

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Price target increased by 9.7% to US$286

Insufficient new directors

Johnson & Johnson Reportedly Considers Deal for Shockwave Medical

Chief Commercial Officer notifies of intention to sell stock

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Independent Director notifies of intention to sell stock

Chief Commercial Officer notifies of intention to sell stock

Shockwave Medical: Opening Arteries, Delivering Returns

New minor risk - Shareholder dilution

Independent Director recently sold US$15m worth of stock

Now 21% undervalued

Consensus EPS estimates increase by 12%

President exercised options and sold US$2.3m worth of stock

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Full year 2023 earnings: EPS exceeds analyst expectations

Shockwave Medical, Inc. Provides Earnings Guidance for 2024

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Shockwave Medical, Inc. Appoints Renee Gaeta as Chief Financial Officer, Effective February 5, 2024

Chief Commercial Officer notifies of intention to sell stock

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

President notifies of intention to sell stock

Shockwave Medical, Inc. to Report Q4, 2023 Results on Feb 15, 2024

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

President notifies of intention to sell stock

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Chief Commercial Officer notifies of intention to sell stock

President exercised options and sold US$922k worth of stock

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Now 21% undervalued after recent price drop

President notifies of intention to sell stock

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Investor sentiment deteriorates as stock falls 25%

Shockwave Medical, Inc. Announces New Data Demonstrating One-Year Outcomes with Coronary Lithotripsy

Now 22% undervalued after recent price drop

Shockwave Medical, Inc. Provides Revenue Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 13% to US$241

Shockwave Medical, Inc. Introduces Enhanced Coronary IVL Catheter in the United States

Shockwave Medical, Inc. Announces New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

President notifies of intention to sell stock

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

President notifies of intention to sell stock

Shockwave Medical, Inc. Appoints Nick West as Associate Chief Medical Officer

Daniel K. Puckett Notifies Shockwave Medical, Inc. of His Intention to Retire as Chief Financial Officer

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?